Singapore-based investment Temasek infuses over Rs 690 crore in Molbio Diagnostics
New Delhi: Healthcare solutions provider Molbio Diagnostics on Monday said Singapore-based investment firm Temasek has invested USD 85 million (over Rs 690 crore) in the company. Goa-based Molbio...
Source: medicaldialogues.in